Table 15.

Total vitamin D intake (µg/day) resulting from the uses of the NF as an ingredient and as a food supplement

Population group	Intake of vitamin D from the background diet EFSA NDA Panel (2012)( g )	Highest P95 vitamin D2 intake from the NF used as an ingredient	Intake of vitamin D2 from the NF used as a food supplement	Total intake( d )	UL (µg/day) EFSA NDA Panel (2012)
Young children	5.6( a )	5.80	15	26.4	50
	15( b )	5.80	–	20.8( c )
Other children	2.7( a )	7.95	15 –	25.7	50
	15( b )	7.95		23.0( c )
Adolescents( e )	4( a )	15.2	15	34.2	100
	8( b )	15.2	–	23.2( c )
Adults( f )	16	13.2	15	44.2	100

UL: tolerable upper intake level; NF: novel food; P95: 95th percentile.

^(a)Maximum mean/median intake of vitamin D from foods only. Data collected from different surveys/studies (EFSA NDA Panel, 2012).

^(b)Combined vitamin D intake from foods and supplements; vitamin D intake from high consumers (90th or 95th percentile depending on surveys) in infants, children and adolescents (EFSA NDA Panel, 2012).

^(c)Dietary intake of vitamin D included in foods and food supplements (EFSA NDA Panel, 2012). In order to avoid overestimation of vitamin D intake, the maximum intake of vitamin D from the total diet (combined intake) does not include the contribution of the vitamin D from the NF used as ingredient in food supplements.

^(d)Total intake is the sum of the intake from the background diet, from NF ingredient use (highest P95) and from the NF used as a food supplement, for each population group.

^(e)If food supplement for all adolescents: Intakes are assessed separately for young [10–14 years] and old adolescent [14–18 years]; the maximum intake among these two subpopulations is reported here.

^(f)Intakes are assessed separately for adults [18–65 years], elderly [65–75 years] and very elderly [≥ 75 years]; the maximum intake among these three subpopulations is reported here.

^(g)P95 intake for adults and highest mean intakes for children and adolescents.